These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9722816)

  • 21. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
    Des Jarlais DC; Arasteh K; Friedman SR
    Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004.
    Nguyen TQ; Gwynn RC; Kellerman SE; Begier E; Garg RK; Pfeiffer MR; Konty KJ; Torian L; Frieden TR; Thorpe LE
    AIDS; 2008 Jan; 22(2):281-7. PubMed ID: 18097231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of methadone treatment on incarceration rates among injection drug users.
    Werb D; Kerr T; Marsh D; Li K; Montaner J; Wood E
    Eur Addict Res; 2008; 14(3):143-9. PubMed ID: 18552490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
    AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug abuse treatment as AIDS prevention.
    Metzger DS; Navaline H; Woody GE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):97-106. PubMed ID: 9722815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    Lehman JS; Allen DM; Green TA; Onorato IM
    AIDS; 1994 Oct; 8(10):1465-9. PubMed ID: 7818818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
    Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone maintenance therapy outcomes in Iran.
    Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and determinants of HIV infection in 581 drug addicts in the Northeastern Italy, from 1984 to 1988].
    Serraino D; Franceschi S; Vaccher E; Tirelli U; Crosatto I; Crovatto M; Moise M
    Epidemiol Prev; 1990 Dec; 12(45):13-8. PubMed ID: 2151322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features.
    Brown LS; Chu A; Nemoto T; Ajuluchukwu D; Primm BJ
    N Y State J Med; 1989 Sep; 89(9):506-10. PubMed ID: 2797531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV infection among members of the Army Reserve components residing in New York City.
    Cowan DN; Brundage JF; Pomerantz RS; Gardner LI; Miller RN; Wann ZF
    N Y State J Med; 1991 Nov; 91(11):479-82. PubMed ID: 1771042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
    Huber-Stemich F; Haas H
    Schweiz Rundsch Med Prax; 1990 Sep; 79(36):1017-21. PubMed ID: 2218224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
    Seligman PJ; Campbell RJ; Keeler GP; Halpin TJ
    Ohio Med; 1989 Jan; 85(1):56-9. PubMed ID: 2927870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.